Chandrasekhar Bal

Broadening horizons with 225Ac-DOTATATE targeted alpha therapy for gastroenteropancreatic neuroendocrine tumour patients stable or refractory to 177Lu-DOTATATE PRRT: first clinical experience on the efficacy and safety

Sanjana Ballal, Madhav Prasad Yadav, Chandrasekhar Bal et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2019 · 201 citations

177Lu-dotatate Prrt, First Clinical Experience, Medicine +9

Prospective randomized clinical trial to evaluate the optimal dose of131I for remnant ablation in patients with differentiated thyroid carcinoma

Chandrasekhar Bal, Ajit Kumar Padhy, Suman Jana et al. · Cancer · 1996 · 162 citations · Full text

Biodistribution, pharmacokinetics, dosimetry of [68Ga]Ga-DOTA.SA.FAPi, and the head-to-head comparison with [18F]F-FDG PET/CT in patients with various cancers

Sanjana Ballal, Madhav Prasad Yadav, Euy Sung Moon et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2020 · 144 citations

Positron Emission Tomography, Neuro-oncology, Oncologic Imaging +10

The role of 18F-fluoride PET-CT in the detection of bone metastases in patients with breast, lung and prostate carcinoma: a comparison with FDG PET/CT and 99mTc-MDP bone scan

Chandrasekhar Bal, Guru Bandopadhyaya, Lalit Kumar et al. · Japanese Journal of Radiology · 2013 · 141 citations

Positron Emission Tomography, Bone Imaging, Medical Imaging +11

¹¹C-Methionine PET for Grading and Prognostication in Gliomas: A Comparison Study with ¹⁸F-FDG PET and Contrast Enhancement on MRI

Tarun Singhal, Tanjore K. Narayanan, Martin Jacobs et al. · Journal of Nuclear Medicine · 2012 · 137 citations · Full text